MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: More prostate cancer screening has little effect

Back to prostate cancer blog Blogs list Cancer blog  


Subscribe To Prostate Cancer Blog RSS Feed  RSS content feed What is RSS feed?

More prostate cancer screening has little effect




More prostate cancers were detected among men who were screened every two years than men screened every four years, as per a research studypublished online August 28 in the Journal of the National Cancer Institute But the shorter time between screenings did not reduce the number of aggressive cancers found between the scheduled screening tests.



More prostate cancer screening has little effect

Since the introduction of PSA (prostate specific antigen) testing in the late 1980s, the occurence rate of prostate cancer has risen dramatically. The rise is mainly due to widespread screening of asymptomatic men. Screening for prostate cancer is a controversial issue because evidence is lacking that PSA screening prevents prostate cancer deaths. Looking at the rate of interval cancerscancers diagnosed based on symptoms during the years between screening testsmay give an indication of how well a screening program is working.

Monique Roobol, Ph.D., of Erasmus Medical Centre in Rotterdam, The Netherlands, and his colleagues conducted a study to determine whether the time between PSA screenings influenced the occurence rate of prostate cancer. They analyzed data collected at two European medical centers that participated in the European Randomized Study of Screening for Prostate Cancer. At a center in Gothenburg, Sweden, 4,202 men were screened every two years, and in Rotterdam, The Netherlands, 13,301 men were screened every four years. The scientists compared both the number and characteristics of the interval prostate cancers diagnosed in these men. Serious, potentially life threatening interval cancers were analyzed separately.

Over a period of ten years, the overall occurence rate of prostate cancer was higher among men screened every two years than among those screened every four years (13.14 percent vs. 8.41 percent). But the total number of interval cancers that were diagnosed between screening tests was 31 (0.74 percent) in Gothenburg and 57 (0.43 percent) in Rotterdam. This difference in the number of interval cancers and the number of aggressive interval cancers at the two centers was not statistically significant, indicating that the two-year screening program did not reduce the number of interval cancers as would be expected.

It is therefore more realistic to think that each screening will again lead to prostate cancer diagnoses among some men from a large pool harboring small and often clinically insignificant disease and thus that more cancers were detected in Sweden because screening was more frequent, the authors write. Additionally, larger cancers seem to be identified with equal effectiveness if screening takes place every 2 or 4 years.

In an accompanying editorial, E. David Crawford, M.D., of the University of Colorado Health Sciences Center in Aurora discusses the controversy surrounding prostate cancer screening and the challenge in determining how often to screen.

Eventhough a number of of us think that early detection is saving lives, definitive evidence is lacking, Crawford writes.


Posted by: Mark    Source




Did you know?
More prostate cancers were detected among men who were screened every two years than men screened every four years, as per a research studypublished online August 28 in the Journal of the National Cancer Institute But the shorter time between screenings did not reduce the number of aggressive cancers found between the scheduled screening tests.

Medicineworld.org: More prostate cancer screening has little effect

Main Page| Cancer blog| Cancer blogs list| Lung cancer blog| Colon cancer blog| Prostate cancer blog| Breast cancer blog| Diabetes watch blog| Heart watch blog| Allergy blog| Bladder cancer blog| Cervical cancer blog| Colon cancer news blog| Diabetes news blog| Esophageal cancer blog| Gastric cancer blog| Health news blog| Heart news blog| Infectious disease blog| Kidney watch blog| Lung disease blog| Lung cancer news blog| Mesothelioma blog| Neurology blog| Breast cancer news blog| OBGYN blog| Ophthalmology blog| Ovarian cancer blog| Cancer news blog| Pancreas cancer blog| Pediatrics blog| Prostate cancer news blog| Psychology blog| Research blog| Rheumatology blog| Society news blog| Uterine cancer blog| Weight watch blog|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.